Liquid biopsy by analysis of circulating myeloma cells and cell-free nucleic acids: a novel noninvasive approach of disease evaluation in multiple myeloma
Authors:
Open Access
- 8 March 2023
- journal article
- review article
- Published by Springer Nature in Biomarker Research
- Vol. 11 (1) , 1-26
Abstract
Multiple myeloma (MM) is an incurable hematological cancer with high spatial- and temporal-heterogeneity. Invasive single-point bone marrow sampling cannot capture the tumor heterogeneity and is difficult to repeat for serial assessments. Liquid biopsy is a technique for identifying and analyzing circulating MM cells and cell products produced by tumors and released into the circulation, allowing for the minimally invasive and comprehensive detection of disease burden and molecular alterations in MM and monitoring treatment response and disease progression. Furthermore, liquid biopsy can provide complementary information to conventional detection approaches and improve their prognostic values. This article reviewed the technologies and applications of liquid biopsy in MM.Keywords
Funding Information
- National Natural Science Foundation of China (81800201)
- Zhejiang Key Research and Development Project (2020C03014)
This publication has 114 references indexed in Scilit:
- Multiple myeloma patients with low proportion of circulating plasma cells had similar survival with primary plasma cell leukemia patientsAnnals of Hematology, 2014
- Deep Sequencing Reveals Myeloma Cells in Peripheral Blood in Majority of Multiple Myeloma PatientsClinical Lymphoma Myeloma and Leukemia, 2014
- Quantification of clonal circulating plasma cells in newly diagnosed multiple myeloma: implications for redefining high-risk myelomaLeukemia, 2014
- Detailed characterization of multiple myeloma circulating tumor cells shows unique phenotypic, cytogenetic, functional, and circadian distribution profileBlood, 2013
- Molecular Monitoring of Minimal Residual Disease in the Peripheral Blood of Patients with Multiple MyelomaTransplantation and Cellular Therapy, 2013
- High levels of peripheral blood circulating plasma cells as a specific risk factor for progression of smoldering multiple myelomaLeukemia, 2012
- Flow cytometric detection of circulating myeloma cells before transplantation in patients with multiple myeloma: a simple risk stratification systemBlood, 2006
- Circulating plasma cells detected by flow cytometry as a predictor of survival in 302 patients with newly diagnosed multiple myelomaBlood, 2005
- Prognostic Value of Circulating Plasma Cells in Monoclonal Gammopathy of Undetermined SignificanceJournal of Clinical Oncology, 2005
- Detection of peripheral blood plasma cells as a predictor of disease course in patients with smouldering multiple myelomaBritish Journal of Haematology, 1994